Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reddy, J. K. & Lalwani, N. D. CRC Crit. Rev. Toxic. 12, 1–58 (1983).
Reddy, J. K. & Rao, M. S. Trends pharmac. Sci. 7, 438–443 (1986).
Nemali, M. R. et al. Toxic. appl. Pharmac. 97, 72–87 (1989).
Lock, E. A., Mitchell, A. M. & Elcombe, C. R. A. Rev. pharmac. Toxicol. 29, 145–163 (1989).
Hess, R., Stäubli, W. & Riess, W. Nature 208, 856–858 (1965).
Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
Styles, J. A., Kelly, M., Pritchard, N. R. & Elcombe, C. R. Carcinogenesis 9, 1647–1655 (1988).
Reddy, J. K. et al. Proc. natn. Acad. Sci. U.S.A. 83, 1747–1751 (1986).
Hijikata, M., Ishii, N., Kagamiyama, H., Osumi, T. & Hashimoto, T. J. biol. Chem. 262, 8151–8158 (1987).
Hardwick, J. P., Song, B.-J., Huberman, E. & Gonzalez, F. J. J. biol. Chem. 262, 801–810 (1987).
Kimura, S., Hardwick, J. P., Kozak, C. A. & Gonzalez, F. J. DNA 8, 517–525 (1989).
Sharma, R. K. et al. Eur. J. Biochem. 184, 69–78 (1989).
Thorp, J. M. & Waring, W. S. Nature 194, 948–949 (1962).
Havel, R. J. & Kane, J. P. A. Rev. Pharmac. 13, 287–308 (1973).
Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
Reddy, J. K. & Qureshi, S. A. Br. J. Cancer 40, 476–482 (1979).
Reddy, J. K., Azarnoff, D. L. & Hignite, C. E. Nature 283, 397–398 (1980).
Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
Conway, J. G. et al. Carcinogenesis 10, 513–519 (1989).
Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
Lalwani, N. D., Fahl, W. E. & Reddy, J. K. Biochem. biophys. Res. Commun. 116, 388–393 (1983).
Lalwani, N. D. et al. Proc. natn. Acad Sci. U.S.A. 84, 5242–5246 (1987).
Green, S. & Chambon, P. Trends Genet. 4, 309–314 (1988).
Evans, R. M. Science 240, 889–895 (1988).
Beato, M. Cell 56, 335–344 (1989).
Kozak, M. Nucleic Acids Res. 15, 8125–8148 (1984).
Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
Giacobino, J.-P. et al. Molec. cell. Endocrin. 61, 217–225 (1989).
Mitchell, A. M., Lhuguenot, J.-C., Bridges, J. W. & Elcombe, C. R. Toxic. appl. Pharmac. 80, 23–32 (1985).
Mitchell, A. M., Bridges, J. W. & Elcombe, C. R. Archs. Toxic. 55, 239–246 (1984).
Kase, B. F., Prydz, K., Björkhem, I. & Pedersen, J. I. Biochem. biophys. Acta 877, 37–42 (1986).
Mader, S., Kumar, V., de Verneuil, H. & Chambon, P. Nature 338, 271–274 (1989).
Umesono, K. & Evans, R. M. Cell 57, 1139–1146 (1989).
Danielsen, M., Hinck, L. & Ringold, G. M. Cell 57, 1131–1138 (1989).
Hapgood, J., Cuthill, S., Denis, M., Poellinger, L. & Gustafsson, J. A. Proc. natn. Acad. Sci. U.S.A. 86, 60–64 (1989).
Elcombe, C. R. & Mitchell, A. M. Environ. Hlth. Perspec. 70, 211–219 (1986).
Lake, B. G., Evans, J. G., Gray, T. J. B., Körösi, S. A. & North, C. J. Toxic. appl. Pharmac. 99, 148–160 (1989).
Hollenberg, S. M. et al. Nature 318, 635–641 (1985).
Green, S. et al. Nature 320, 134–139 (1986).
Baker, A. R. et al. Proc. natn. Acad. Sci. U.S.A. 85, 3294–3298 (1988).
Weinberger, C. et al. Nature 324, 641–646 (1986).
Petkovich, M., Brand, N. J., Krust, A. & Chambon, P. Nature 330, 444–450 (1987).
Giguere, V., Ong, E. S., Segui, P. & Evans, R. M. Nature 330, 624–629 (1987).
Lathe, R. J. molec. Biol. 183, 1–12 (1985).
Miyajima, N. et al. Cell 57, 31–39 (1989).
Feigl, G., Gram, M. & Pongs, O. Nucleic Acids Res. 17, 7167–7178 (1989).
Seagraves, W. A. & Hogness, D. S. Genes Devel. 4, 204–219 (1990).
Hamada, K. et al. Proc. natn. Acad. Sci. U.S.A. 86, 8289–8293 (1989).
Current Protocols in Molecular Biology (Wiley, New York, 1990).
Webster, N. J. G., Green, S., Jin, J. R. & Chambon, P. Cell 54, 199–207 (1988).
Green, S., Issemann, I. & Scheer, E. Nucleic Acids Res. 16, 369 (1988).
Kumar, V. et al. Cell 51, 941–951 (1987).
Green, S. & Chambon, P. Nature 325, 75–78 (1987).
Saiki, R. K. et al. Science 239, 487–491 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Issemann, I., Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645–650 (1990). https://doi.org/10.1038/347645a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/347645a0
This article is cited by
-
Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease
Nutrition & Metabolism (2024)
-
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021–2023)
Molecular Diversity (2024)
-
Peroxisome proliferator-activated receptor-α activation facilitates contextual fear extinction and modulates intrinsic excitability of dentate gyrus neurons
Translational Psychiatry (2023)
-
Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer
Functional & Integrative Genomics (2023)
-
Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism
Scientific Reports (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.